According to Strides Pharma's latest financial reports the company has $52.14 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $43.93 M | 80.88% |
2022-03-31 | $24.28 M | -35.1% |
2021-03-31 | $37.42 M | -18.87% |
2020-03-31 | $46.13 M | -59.58% |
2019-03-31 | $0.11 B | 22.26% |
2018-03-31 | $93.34 M | -65.15% |
2017-03-31 | $0.26 B | 16.56% |
2016-03-31 | $0.22 B | 92.32% |
2015-03-31 | $0.11 B | |
2012-12-31 | $24.11 M | -39.69% |
2011-12-31 | $39.97 M | -85.36% |
2010-12-31 | $0.27 B | 375.78% |
2009-12-31 | $57.38 M | 50.99% |
2008-12-31 | $38 M | -54.02% |
2007-12-31 | $82.65 M | 186.6% |
2006-12-31 | $28.83 M | -13.51% |
2005-12-31 | $33.34 M | 105.02% |
2004-12-31 | $16.26 M |